Xeris Biopharma Holdings, Inc. Quarterly Operating Leases, Future Minimum Payments, Due in Three Years in USD from Q3 2021 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of required minimum rental payments for operating leases having an initial or remaining non-cancelable lease term in excess of one year due in the third fiscal year following the latest fiscal year. Excludes interim and annual periods when interim periods are reported on a rolling approach, from latest balance sheet date.
Summary
Xeris Biopharma Holdings, Inc. quarterly Operating Leases, Future Minimum Payments, Due in Three Years history and growth rate from Q3 2021 to Q3 2022.
  • Xeris Biopharma Holdings, Inc. Operating Leases, Future Minimum Payments, Due in Three Years for the quarter ending September 30, 2022 was $6.08M, a 199% increase year-over-year.
Operating Leases, Future Minimum Payments, Due in Three Years, Quarterly (USD)
Operating Leases, Future Minimum Payments, Due in Three Years, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2022 $6.08M +$4.05M +199% Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $1.98M Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $1.98M Mar 31, 2022 10-Q 2022-05-11
Q4 2021 $1.98M Dec 31, 2021 10-K 2023-03-08
Q3 2021 $2.03M Sep 30, 2021 10-Q 2021-11-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.